课题基金 / 基金详情

Cyclin E: Implications for targeted therapy in HER2-overexpressing breast cancer

Cyclin E: Implications for targeted therapy in HER2-overexpressing breast cancer
Cyclin E:HER2 过表达乳腺癌靶向治疗的意义
批准号:
8135313
负责人:
Elizabeth Mittendorf
金额:
$23.74万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-16 至 2013-08-31

项目成果

Elizabeth Mittendorf的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
Cyclin E: Implications for targeted therapy in HER2-overexpressing breast cancer
Cyclin E: Implications for targeted therapy in HER2-overexpressing breast cancer
Cyclin E: Implications for targeted therapy in HER2-overexpressing breast cancer
海外基金